Volume 8 - Continuous publishing                   Iran J Neurosurg 2022, 8 - Continuous publishing: 13-13 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Faritous S Z, Hashemi Z, Hajiesmaeili M, Morshedizad Z, Bakhshandeh H, Mehrabimahani S. The Effectiveness of Selenium in Oral Nutritional Therapy for Patients With Subarachnoid Hemorrhage. Iran J Neurosurg 2022; 8 :13-13
URL: http://irjns.org/article-1-302-en.html
1- Department of Anesthesiology, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran
2- Department of ICU, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran
3- Anesthesiology Research Center, Loghman Hakim Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
4- Department of Cardiac Anesthesia, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran , zmorshedizad@gmail.com
5- Department of Epidemiology, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran
6- Department of Cardiac Anesthesia, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran
Abstract:   (527 Views)
Background and Aim: Every year, traumatic brain injuries lead to more than one million admissions to emergency rooms and more than 50,000 deaths, and millions of disabilities worldwide, among all ages and genders. This study aimed to examine the effects of selenium added to oral nutritional therapy on the mortality rate and length of hospital stay in patients with subarachnoid hemorrhage admitted to the intensive care unit (ICU) for six months.
Methods and Materials/Patients: This clinical trial included 100 patients admitted to the ICU of Loghman Hakim Hospital, Tehran, Iran. These patients were then randomly assigned to intervention or control groups. Standard oral solutions were administered to both groups according to recommended guidelines. Along with the standard nutritional intake, the participants in the intervention group were given 1000 μg of selenium (Selenase-Biosyn, Germany) on the first day of feeding, dissolved in 100 mL of normal saline for 30 minutes, followed by 500μg of selenium daily for 10 days. We screened patients for GCS, and APACHE-II scores, as well as cortisol levels on days 1 and 10.
Results: The APACHE-II mean score on the 10th day was significantly different between the two groups, and this was also true before the intervention. In terms of mortality rates, there was no significant difference between the control group and the intervention group. Neither the control group nor the intervention group spent significantly more time in ICU.
Conclusion: The effects of selenium on other variables were unclear, although mortality rates did not differ significantly between the two groups. Considering the confounding variables through regression analysis, the APACHE-II variable was negatively impacted by selenium, but taking into account the significant effect of age, a definitive conclusion cannot be made.
Full Text [PDF 1314 kb]   (99 Downloads) |   |   Full Text (HTML)  (14 Views)  
Type of Study: Research | Subject: Neurotrauma

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2022 CC BY-NC 4.0 | Iranian Journal of Neurosurgery

Designed & Developed by : Yektaweb